Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Panacea Biotec is a leading Indian biotechnology and pharmaceutical company specializing in the research, development, and large-scale manufacturing of vaccines and specialty therapeutics. The company is globally recognized for its role in public health, serving as a major supplier of oral polio vaccines to international organizations like UNICEF and the WHO. Its diverse product portfolio spans oncology, organ transplantation, diabetes, and nephrology, often leveraging advanced drug delivery technologies such as nanoparticle-based formulations. Panacea Biotec maintains a robust R&D pipeline featuring next-generation vaccines for dengue and pneumococcal diseases, alongside a range of biosimilars. Headquartered in New Delhi, the company operates multiple state-of-the-art manufacturing facilities that comply with international regulatory standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Panacea Laboratories.